{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dyspepsia-unidentified-cause/prescribing-information/tetracycline/","result":{"pageContext":{"chapter":{"id":"640d4b46-3f9c-5cef-aeda-9a374a03fae8","slug":"tetracycline","fullItemName":"Tetracycline","depth":2,"htmlHeader":"<!-- begin field a4d10989-91bf-4cd9-aea0-a77c01470414 --><h2>Tetracycline</h2><!-- end field a4d10989-91bf-4cd9-aea0-a77c01470414 -->","summary":"","htmlStringContent":"<!-- begin item c149c0f8-b77b-41da-a811-a77c014702ae --><!-- end item c149c0f8-b77b-41da-a811-a77c014702ae -->","topic":{"id":"f89632d0-8e52-59da-bd63-555a73aa134f","topicId":"ac596995-c452-4bf5-81bf-0aea66eca309","topicName":"Dyspepsia - unidentified cause","slug":"dyspepsia-unidentified-cause","lastRevised":"Last revised in October 2018","chapters":[{"id":"9fdd530d-f12b-5642-954b-6284524a3fdb","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"4ac2b712-5571-56ca-9ac4-25c9e354a821","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"16fcbe75-c057-5b25-8039-9145eb897f12","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"be6e1eb9-7eb4-54b8-980d-7a18a90127c3","slug":"changes","fullItemName":"Changes"},{"id":"8eb7dbc2-40da-5433-b290-44902a364d61","slug":"update","fullItemName":"Update"}]},{"id":"a44ffd66-34ee-565e-8b89-d09f62dd9656","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"ad917944-2a8c-561c-ba7d-5e5c7ea860e4","slug":"goals","fullItemName":"Goals"},{"id":"cbb4bad0-1dbe-5c62-9adc-bb1a65fe6381","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"54d592f8-f244-5cc8-aed5-81cb136af042","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4ca8a0b2-46c5-52c2-a05d-1ae84806cefd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c5e33c66-dee5-57d8-9eff-828ad855e204","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"eff9b41a-cac2-5b9a-8614-2486d8206ffd","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4dfc51d9-1416-5432-bc80-019f5708238c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ec8766af-6b0a-5a4d-8897-2e3ba2af658d","slug":"definition","fullItemName":"Definition"},{"id":"e1cbef45-8ac7-5376-a1d2-c5d0a2cc924b","slug":"causes","fullItemName":"Causes"},{"id":"c7487dda-a4e1-5d9e-bc96-e583302af12c","slug":"prevalence","fullItemName":"Prevalence"}]},{"id":"0eb82dd3-e433-5b8e-a8d9-46987aab8940","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d2acef31-cf6d-5e3e-b2e0-99bc02684183","slug":"assessment","fullItemName":"Assessment"},{"id":"86ebd63c-3596-5ac0-9cd3-4a312bb2d7e4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f244ecd9-294a-5fa3-9b22-a2e8f2ae408c","fullItemName":"Management","slug":"management","subChapters":[{"id":"bafb1a12-7cf3-5c6c-921a-03d86efd995d","slug":"dyspepsia-unidentified-cause","fullItemName":"Scenario: Dyspepsia - unidentified cause"}]},{"id":"b50160d9-c6d3-5b75-a3a3-9a743c039fb4","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"2978bf31-384a-5964-bba7-5ca72e2a700a","slug":"proton-pump-inhibitors-ppis","fullItemName":"Proton pump inhibitors (PPIs)"},{"id":"a51b3918-0bed-5c45-887b-a5d3e5fd3031","slug":"h2-receptor-antagonists","fullItemName":"H2-receptor antagonists"},{"id":"8579e41d-876a-5f82-9cb8-04675dce1bb3","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"d41b619e-ef9e-59b6-876b-0b3d52f0884a","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"9ea259a4-6c7f-524f-8866-6164a9696c25","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"640d4b46-3f9c-5cef-aeda-9a374a03fae8","slug":"tetracycline","fullItemName":"Tetracycline"},{"id":"fe5b2b68-8d84-5867-bc39-c63cbcd815f8","slug":"levofloxacin","fullItemName":"Levofloxacin"},{"id":"0857fa25-e261-5ecd-b851-fbe52518072d","slug":"bismuth","fullItemName":"Bismuth"}]},{"id":"210b1a7b-a0e0-558a-acbe-539f538e840d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"0e0cffca-8140-5660-bd87-d4288485522f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"4726f06d-25b6-56d1-83c0-3d729c2bb571","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"301b4d9b-8d13-5cc1-8e9a-f8f68c4fa019","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5e963a22-e16a-5e4a-b7a9-072decaccaa1","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d1d047d4-3011-5ca0-955c-b366ab2a9fb4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"cd5de0cc-ba55-5ad9-b09b-3025cc68334c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"cc0ebb19-4869-5b31-8bcf-f0b6e5af54db","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b50160d9-c6d3-5b75-a3a3-9a743c039fb4","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"c1ba4693-25d9-595c-99ef-464647f524fa","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 861a0c28-3073-4d4e-98b8-a77c01472f1f --><h3>Contraindications and cautions</h3><!-- end field 861a0c28-3073-4d4e-98b8-a77c01472f1f -->","summary":"","htmlStringContent":"<!-- begin item 907bb51a-3e7e-4f02-9a99-a77c01472d5a --><!-- begin field 29c87a74-6f9d-453c-a3ec-a77c01472f1f --><ul><li><strong>Do not prescribe tetracycline to people with:</strong><ul><li>Renal impairment — tetracyclines are excreted renally and may exacerbate renal failure.</li></ul></li><li><strong>Prescribe tetracycline with caution to people with:</strong><ul><li>Hepatic impairment and those receiving potentially hepatotoxic drugs, such as carbamazepine, isoniazid, and methotrexate.</li><li>Myasthenia gravis — tetracyclines may increase muscle weakness symptoms.</li><li>Systemic lupus erythematosus (SLE) — tetracyclines may exacerbate the condition.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-unidentified-cause/references/\">BNF 73, 2017</a>]</p><!-- end field 29c87a74-6f9d-453c-a3ec-a77c01472f1f --><!-- end item 907bb51a-3e7e-4f02-9a99-a77c01472d5a -->","subChapters":[]},{"id":"38717df9-5c95-5775-903a-d470ac2891bf","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field c97addba-4ce6-48ee-ab70-a77c01474541 --><h3>Adverse effects</h3><!-- end field c97addba-4ce6-48ee-ab70-a77c01474541 -->","summary":"","htmlStringContent":"<!-- begin item 1624c847-648d-4beb-b576-a77c0147434c --><!-- begin field 4abeb91d-43aa-4a60-ae8b-a77c01474541 --><ul><li><strong>Common adverse effects of tetracycline include:</strong><ul><li>Gastrointestinal disturbances such as nausea, vomiting, and diarrhoea.<ul><li>Consider pseudomembranous colitis if a person develops severe diarrhoea during or after treatment with tetracycline. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li></ul></li><li>Dysphagia and oesophageal irritation.</li></ul></li><li><strong>Other rare adverse effects of tetracyclines include:</strong><ul><li>Severe headache and/or visual disturbance — may be an early symptom of benign intracranial hypertension. Stop treatment and seek immediate medical advice if this is suspected.</li><li>Severe oesophagitis.</li><li>Vulvovaginal candidiasis.</li><li>Photosensitivity.</li><li>Hepatotoxicity, pancreatitis.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-unidentified-cause/references/\">BNF 73, 2017</a>]</p><!-- end field 4abeb91d-43aa-4a60-ae8b-a77c01474541 --><!-- end item 1624c847-648d-4beb-b576-a77c0147434c -->","subChapters":[]},{"id":"7f889636-07a0-5104-840e-9757dd1552db","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field cb4f4492-d9be-4e18-a05f-a77c01477682 --><h3>Drug interactions</h3><!-- end field cb4f4492-d9be-4e18-a05f-a77c01477682 -->","summary":"","htmlStringContent":"<!-- begin item ca1334e6-47d4-450b-a040-a77c014759e0 --><!-- begin field 7d2f80b8-ee68-444f-ad6a-a77c01477682 --><p><strong>Possible drug interactions with tetracycline include:</strong></p><ul><li><strong>Antacids (containing aluminium, bismuth, calcium, or magnesium) and other medications containing iron or zinc </strong>— these reduce the absorption of tetracyclines if taken concurrently.<ul><li>Avoid taking antacids and other medications containing iron or zinc, 2 hours before or after taking tetracyclines.</li></ul></li><li><strong>Anticoagulants </strong><strong>—</strong> the concurrent use of warfarin with tetracyclines can increase the anticoagulant effect of coumarins.<ul><li>Monitor the person's international normalized ratio (INR) regularly and within 3 days of starting the tetracycline. Adjust the warfarin dose accordingly.</li></ul></li><li><strong>Retinoids</strong> — there is a possible increased risk of benign intracranial pressure if tetracyclines are used concurrently with retinoids.<ul><li>Avoid the concurrent use of tetracyclines and retinoids.</li></ul></li><li><strong>Milk </strong>— the absorption of most tetracyclines is reduced by the calcium found in milk and other dairy products.</li><li><strong>Carbamazepine </strong>— doxycycline levels are reduced significantly in people taking long-term carbamazepine.</li><li><strong>Penicillins </strong>— tetracyclines possibly antagonize the effects of penicillins.</li><li><strong>Sulfonylureas </strong>— tetracyclines possibly enhance the hypoglycaemic effects of sulfonylureas.</li><li><strong>Tripotassium dicitratobismuthate</strong> — absorption of tetracyclines is reduced.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-unidentified-cause/references/\">BNF 73, 2017</a>]</p><!-- end field 7d2f80b8-ee68-444f-ad6a-a77c01477682 --><!-- end item ca1334e6-47d4-450b-a040-a77c014759e0 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}